PMID- 11816828
OWN - NLM
STAT- MEDLINE
DCOM- 20020403
LR  - 20131121
IS  - 0904-1850 (Print)
IS  - 0904-1850 (Linking)
VI  - 32
DP  - 2001 Sep
TI  - Drug-induced infiltrative lung disease.
PG  - 93s-100s
AB  - An increasing number of drugs are recognized to induce distinctive patterns of 
      infiltrative lung disease (ILD), ranging from benign infiltrates to 
      life-threatening adult respiratory distress syndromes. In addition to drugs, 
      biomolecules such as proteins and cytokines, and medicinal plants are also 
      capable of inducing respiratory disease, some being severe and/or irreversible. 
      For several reasons it is difficult to estimate the exact frequency of 
      drug-induced infiltrative lung disease (DI-ILD). The risk for DI-ILD and the 
      clinical patterns vary depending on a variety of host and drug factors. Although 
      establishing the diagnosis is often difficult, systematic evaluation of the 
      possible role of almost any kind of drugs in ILD is warranted, as stopping a drug 
      may favourably influence prognosis. However, prognosis depends on the drug and 
      the type of DI-ILD. Corticosteroids may suppress the inflammatory reaction, but 
      for many drugs, proof of the effect of corticosteroids is lacking. Advances in 
      prevention and prediction are needed. A user-friendly database of respiratory 
      adverse drug reactions was made available on the web, to provide quick 
      information in this area.
FAU - Camus, P H
AU  - Camus PH
AD  - Service de Pneumologie et de Reanirnation Respiratoire, Centre Hospitalier 
      Universitaire de Dijon, Universite de Bourgogne, France.
FAU - Foucher, P
AU  - Foucher P
FAU - Bonniaud, P H
AU  - Bonniaud PH
FAU - Ask, K
AU  - Ask K
LA  - eng
PT  - Journal Article
PT  - Review
PL  - England
TA  - Eur Respir J Suppl
JT  - The European respiratory journal. Supplement
JID - 8910681
SB  - IM
MH  - Drug Hypersensitivity/etiology
MH  - Drug Therapy/trends
MH  - Drug-Related Side Effects and Adverse Reactions
MH  - Europe/epidemiology
MH  - Forecasting
MH  - Humans
MH  - Lung Diseases, Interstitial/*chemically induced/diagnosis
MH  - Prognosis
MH  - Risk Factors
RF  - 151
EDAT- 2002/01/31 10:00
MHDA- 2002/04/04 10:01
CRDT- 2002/01/31 10:00
PHST- 2002/01/31 10:00 [pubmed]
PHST- 2002/04/04 10:01 [medline]
PHST- 2002/01/31 10:00 [entrez]
PST - ppublish
SO  - Eur Respir J Suppl. 2001 Sep;32:93s-100s.